Laurent Pharmaceuticals Inc. (the “Company”), a biopharmaceutical company focusing on rare diseases, today announced that it has received the final approval for a CAD 2.7M loan from the Quebec Government…
Laurent Pharmaceuticals Inc. (the “Company”), today announced that it has reached an agreement to receive an additional funding of up to US$ 3 million from the US-based Cystic Fibrosis Foundation (the “Foundation”) to further…
Laurent Pharmaceuticals Inc., a biopharmaceutical company developing LAU-7b (oral fenretinide) first-in-class pro-resolving drug for Cystic Fibrosis (CF), today announced new financing led by Keiretsu Forum Mid- Atlantic, Anges Quebec and…